Projects / Programmes
Identification of new disease mechanisms with next generation sequencing
Code |
Science |
Field |
Subfield |
3.05.00 |
Medical sciences |
Human reproduction |
|
Code |
Science |
Field |
B007 |
Biomedical sciences |
Medicine (human and vertebrates) |
Code |
Science |
Field |
3.02 |
Medical and Health Sciences |
Clinical medicine |
Next-generation sequencing, exome sequencing, monogenic (Mendelian) syndromes, multifactorial diseases
Researchers (15)
no. |
Code |
Name and surname |
Research area |
Role |
Period |
No. of publicationsNo. of publications |
1. |
20078 |
Barbara Dolničar |
|
Technical associate |
2013 - 2016 |
4 |
2. |
00814 |
PhD Ksenija Geršak |
Human reproduction |
Researcher |
2013 - 2016 |
530 |
3. |
26061 |
PhD Helena Jaklič |
Human reproduction |
Researcher |
2013 - 2016 |
37 |
4. |
37651 |
Esada Kerić |
|
Technical associate |
2015 - 2016 |
0 |
5. |
34579 |
PhD Aleš Maver |
Human reproduction |
Junior researcher |
2013 - 2016 |
201 |
6. |
31217 |
Iryna Nikolayeva |
|
Technical associate |
2013 - 2016 |
0 |
7. |
10458 |
PhD Borut Peterlin |
Human reproduction |
Head |
2013 - 2016 |
847 |
8. |
28621 |
Bernarda Prosenc |
Human reproduction |
Technical associate |
2013 - 2016 |
0 |
9. |
21133 |
MSc Gorazd Rudolf |
Human reproduction |
Researcher |
2013 - 2016 |
51 |
10. |
23076 |
Andrej Stegnar |
|
Technical associate |
2013 - 2016 |
0 |
11. |
15149 |
PhD Nataša Teran |
Human reproduction |
Researcher |
2013 - 2016 |
97 |
12. |
12245 |
Alenka Veble |
Human reproduction |
Researcher |
2013 - 2016 |
71 |
13. |
26331 |
Marija Volk |
Human reproduction |
Researcher |
2013 - 2016 |
87 |
14. |
32544 |
Irena Vrečar |
Public health (occupational safety) |
Researcher |
2013 - 2016 |
9 |
15. |
20257 |
PhD Karin Writzl |
Human reproduction |
Researcher |
2013 - 2016 |
210 |
Organisations (1)
Abstract
Methods of next generation sequencing (NGS) provide the possibility of sequencing complete human exome and genome at accessible cost. These methods offer the opportunity to discover genes for monogenic diseases, even when the number of affected individuals in a family is small, and only a single affected individual might be sufficient to find the causative variant. In multifactorial diseases, NGS methods have potential to detect very rare but highly penetrant genetic variants, especially in familial forms of such diseases.
Two main current challenges in application of NGS include: 1) to identify individuals and families with monogenic diseases, where genetic etiology is not yet known, or to identify families with common chronic diseases, where causative mutations reside in one or more newly discovered genes; and 2) to improve methods of interpretation of exome/genome analysis for identification of pathogenic mutation among the multitude of genetic variants detected by exome/genome sequencing.
During our clinical an research activities performed at the Clinical institute of medical genetics UKCL, we have already identified a new syndrome multiple sclerosis/malignant melanoma, a familial form of premature ovarian failure with signs of masculinization, two cases of premature aging with unknown genetic etiology and some other very rare, etiologically unexplained syndromes as well as rare familial cases of multiple sclerosis, where understanding of etiology is still very limited.
The aim of the proposed project is therefore to analyze exomes of already ascertained patients with rare syndromes and familial form of multiple sclerosis and to identify new genes and pathological mechanisms for multiple sclerosis, malignant melanoma, premature ovarian failure, premature aging and other rare syndromes that we have already identified, as well for the diseases to be still collected during the project. Additionally, we aim to develop bioinformatic approaches for efficient identification of pathogenic variants in exome/genome analyses with integration of BITOLA tool and integratomic approach into the pathogenic variant discovery.
Significance for science
We developed new bioinformatic tools for interpratation of exome sequencing results and web-based application Phenotype Generator Panel (http://www.kimg.eu/generator/). We managed to identify 4 new genes for 3 human disorders: the progeroid syndrome Fontaine Petty, epilepsies and multiple sclerosis and consequently discovered new pathological mechanisms of mentioned diseases. New mechanisms provide potential for development of new therapeutic approaches.
Significance for the country
Development of new diagnostic appraches for diagnosis of genetic diseases and its implementation in the national health care system has significantly contributed to the access of Slovene patients with rare diseases to rapid diagnosis. This is line with the Slovene national plan for rare diseases. Additionally the project contributed to the competitiveness of the Slovene health sector as the Clinical Institute of Human Genetics developed as one of the major providers of exome sequencing in the region.
Most important scientific results
Annual report
2013,
2014,
2015,
final report
Most important socioeconomically and culturally relevant results
Annual report
2013,
2014,
2015,
final report